Article metrics

Original research
Clinical activity of durvalumab for patients with advanced mismatch repair-deficient and repair-proficient endometrial cancer. A nonrandomized phase 2 clinical trial

 

Online download statistics by month:

Online download statistics by month: to

AbstractFullPdf
Total000